This new microsite, live from 1 June, will be your essential resource on child protection and safeguarding - whether you are involved with child protection as a child health professional, allied health professional, social worker, solicitor or barrister.
17 March 2020
The RCPCH/NPPG Medicines Committee has recently been informed of a severe adverse reaction in a six-month old child with anisocoria who had been administered apraclonidine 1% to help exclude Horner syndrome.
2 March 2020
The Medicines and Healthcare products Regulatory Agency (MHRA) is requesting that healthcare professionals report any suspected side effects or safety concerns with e-cigarettes and the e-liquids used for vaping to the Yellow Card Scheme.
5 February 2020
Dr Mike Linney, Registrar and Chair of the Ethics Committee for RCPCH, welcomes recent guidance from NICE, but notes the urgent need for high quality, independent research on this medicine to provide the best possible care for children with complex epilepsy.
The Medicines and Healthcare products Regulatory Agency (MHRA) “Yellow Card Scheme” is the UK system for collecting and monitoring information on suspected safety concerns or incidents involving side effects to medicines (also known as adverse drug reactions or ADRs) and medical devices.
Experts from 13 national bodies, including seven Royal Colleges, joined forces in March 2019 to launch practical guidance to support doctors and other health professionals around the use of this medicine in women and girls in their reproductive years.
16 December 2019
Domperidone is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg because of a lack of evidence for benefit.
This report highlights the key findings and recommendations from the analysis of the data provided by neonatal units on the admissions of babies for neonatal care in England, Scotland and Wales in 2018.
One in seven babies born in the UK will spend at least a few days in hospital in a neonatal unit which specialises in looking after babies who are born early, with a low weight or who have a medical condition that needs specialist treatment.
This high quality leaflet gives information to parents and carers of children and young people who have had a first seizure that was not considered to be a ‘febrile convulsion’. We're working on a version for children and young people. We explain why and how we developed this information.